¡¸¾¾¾Ë¸®½ºµ¥Àϸ® ¡¼Ä«ÅåEXBB¡½¡¹
¾÷°è ÃÖÃÊ ÃÑ¾Ë¹ß¼Û ½Ã½ºÅÛ
100% ÈĺÒÁ¦¸¸ °¡´É
¾¾¾Ë¸®½ºµ¥Àϸ® < ¹Ù·Î°¡±â >
¾¾¾Ë¸®½ºµ¥Àϸ® < ¹Ù·Î°¡±â >
Á¤Ç°Ä«¸¶±×¶ó¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®½Ã¾Ë¸®½º±¸¸Å
ºñ¾Æ±×¶ó ±¸¸Å¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®ÇÁ¸±¸®Áö ±¸¸Å
ÆÄ¿ö¸Ç ºñ¾Æ±×¶ó¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®¾¾¾Ë¸®½ºµ¥Àϸ®ÆÄ¿ö¸Ç
¾¾¾Ë¸®½ºµ¥Àϸ® ¾¾¾Ë¸®½ºµ¥Àϸ®Ã³¹æ¹Þ±â ¾¾¾Ë¸®½ºµ¥Àϸ®¾ÆÀ̵¹ ¾¾¾Ë¸®½ºµ¥Àϸ®¿©¼º ¾¾¾Ë¸®½ºµ¥Àϸ®Á¤Ç°°¡°Ý ¾¾¾Ë¸®½ºµ¥Àϸ®°¡Â¥ ¾¾¾Ë¸®½ºµ¥Àϸ®È¸»ç ¾¾¾Ë¸®½ºµ¥Àϸ®Á¤Ç°±¸ÀÔ ¾¾¾Ë¸®½ºµ¥Àϸ®¹Ù¸£´Â ¾¾¾Ë¸®½ºµ¥Àϸ®°ñµå ¾¾¾Ë¸®½ºµ¥Àϸ®¿ë·® ¾¾¾Ë¸®½ºµ¥Àϸ®Ç÷¾Ð ¾¾¾Ë¸®½ºµ¥Àϸ®°¡·ç ¾¾¾Ë¸®½ºµ¥Àϸ®50mg°¡°Ý ¾¾¾Ë¸®½ºµ¥Àϸ®È¿°ú¾øÀ½ ¾¾¾Ë¸®½ºµ¥Àϸ®Á¤Ç°±¸¸Å ¾¾¾Ë¸®½ºµ¥Àϸ®½´ÆÛ ¾¾¾Ë¸®½ºµ¥Àϸ®±¸ÀÔó ¾¾¾Ë¸®½ºµ¥Àϸ®Å»¸ðÄ¡·á ¾¾¾Ë¸®½ºµ¥Àϸ®Á¤·Â°¨Åð ¾¾¾Ë¸®½ºµ¥Àϸ®ÈÞ´ë ¾¾¾Ë¸®½ºµ¥Àϸ®10mg ¾¾¾Ë¸®½ºµ¥Àϸ®¼·Ãë ¾¾¾Ë¸®½ºµ¥Àϸ®°æ±¸¿ë ¾¾¾Ë¸®½ºµ¥Àϸ®±¹»ê ¾¾¾Ë¸®½ºµ¥Àϸ®ºÎÀÛ¿ë½ÉÀå ¾¾¾Ë¸®½ºµ¥Àϸ®Á¦³×¸¯°¡°Ý ¾¾¾Ë¸®½ºµ¥Àϸ®3¾Ë ¾¾¾Ë¸®½ºµ¥Àϸ®25mg ¾¾¾Ë¸®½ºµ¥Àϸ®Ä«µå°áÁ¦ ¾¾¾Ë¸®½ºµ¥Àϸ®¸ÔÀºÈıâºÐ ¾¾¾Ë¸®½ºµ¥Àϸ®¸Ô´ÂÀÌÀ¯ ¾¾¾Ë¸®½ºµ¥Àϸ®ÆĴ°÷ ¾¾¾Ë¸®½ºµ¥Àϸ®³²¼º ¾¾¾Ë¸®½ºµ¥Àϸ®ÆĴ°÷ ¾¾¾Ë¸®½ºµ¥Àϸ®Ã³¹æ¹Þ±â¾¾¾Ë¸®½ºµ¥Àϸ®°£¼öÄ¡ ¾¾¾Ë¸®½ºµ¥Àϸ®Åº»ý ¾¾¾Ë¸®½ºµ¥Àϸ®Á© ¾¾¾Ë¸®½ºµ¥Àϸ®ÆĴ°÷ ¾¾¾Ë¸®½ºµ¥Àϸ®¹ß¸í ¾¾¾Ë¸®½ºµ¥Àϸ®±¤°í ¾¾¾Ë¸®½ºµ¥Àϸ®3µîºÐ ¾¾¾Ë¸®½ºµ¥Àϸ®obscure ¾¾¾Ë¸®½ºµ¥Àϸ®apart ¾¾¾Ë¸®½ºµ¥Àϸ®bombing ¾¾¾Ë¸®½ºµ¥Àϸ®shot ¾¾¾Ë¸®½ºµ¥Àϸ®girlfriend ¾¾¾Ë¸®½ºµ¥Àϸ®ceiling ¾¾¾Ë¸®½ºµ¥Àϸ®tree ¾¾¾Ë¸®½ºµ¥Àϸ®light ¾¾¾Ë¸®½ºµ¥Àϸ®relate ¾¾¾Ë¸®½ºµ¥Àϸ®aware ¾¾¾Ë¸®½ºµ¥Àϸ®revenue ¾¾¾Ë¸®½ºµ¥Àϸ®name ¾¾¾Ë¸®½ºµ¥Àϸ®context ¾¾¾Ë¸®½ºµ¥Àϸ®admiration ¾¾¾Ë¸®½ºµ¥Àϸ®gloomy ¾¾¾Ë¸®½ºµ¥Àϸ®promise ¾¾¾Ë¸®½ºµ¥Àϸ®objective ¾¾¾Ë¸®½ºµ¥Àϸ®defense ¾¾¾Ë¸®½ºµ¥Àϸ®eye ¾¾¾Ë¸®½ºµ¥Àϸ®recession ¾¾¾Ë¸®½ºµ¥Àϸ®appropriate ¾¾¾Ë¸®½ºµ¥Àϸ®critic ¾¾¾Ë¸®½ºµ¥Àϸ®agreement ¾¾¾Ë¸®½ºµ¥Àϸ®ambition ¾¾¾Ë¸®½ºµ¥Àϸ®sensitive ¾¾¾Ë¸®½ºµ¥Àϸ®order ¾¾¾Ë¸®½ºµ¥Àϸ®fee¾¾¾Ë¸®½ºµ¥Àϸ® ¾¾¾Ë¸®½ºµ¥Àϸ®È¸»ç ¾¾¾Ë¸®½ºµ¥Àϸ®Çõ¸í ¾¾¾Ë¸®½ºµ¥Àϸ®ºñ´¢±â°úó¹æ ¾¾¾Ë¸®½ºµ¥Àϸ®°¡·ç ¾¾¾Ë¸®½ºµ¥Àϸ®µµ¼Ò¿ë¾øÀÌ ¾¾¾Ë¸®½ºµ¥Àϸ®±â³»¹ÝÀÔ ¾¾¾Ë¸®½ºµ¥Àϸ®¿ë·® ¾¾¾Ë¸®½ºµ¥Àϸ®Áß±¹»ê ¾¾¾Ë¸®½ºµ¥Àϸ®¿©¼º¿ë ¾¾¾Ë¸®½ºµ¥Àϸ®100¹Ð¸®±×¶÷ ¾¾¾Ë¸®½ºµ¥Àϸ®±¸ÀÔó¹æÀü ¾¾¾Ë¸®½ºµ¥Àϸ®¸ÅÀϺ¹¿ë ¾¾¾Ë¸®½ºµ¥Àϸ®±¸ÀÔ¹æ¹ý ¾¾¾Ë¸®½ºµ¥Àϸ®°£¼öÄ¡ ¾¾¾Ë¸®½ºµ¥Àϸ®¸ÔÀºÈıâºÐ ¾¾¾Ë¸®½ºµ¥Àϸ®¿¤°¡°Ý ¾¾¾Ë¸®½ºµ¥Àϸ®Á¤Ç°°¡°Ý ¾¾¾Ë¸®½ºµ¥Àϸ®3¾Ë ¾¾¾Ë¸®½ºµ¥Àϸ®Ã³¹æ¹æ¹ý ¾¾¾Ë¸®½ºµ¥Àϸ®°øº¹ ¾¾¾Ë¸®½ºµ¥Àϸ®È£ÁÖ ¾¾¾Ë¸®½ºµ¥Àϸ®º¹Á¦¾à°¡°Ý ¾¾¾Ë¸®½ºµ¥Àϸ®¾ÆÀ̽ºÅ©¸² ¾¾¾Ë¸®½ºµ¥Àϸ®ÇÑ±Û ¾¾¾Ë¸®½ºµ¥Àϸ®ÆǸÅó ¾¾¾Ë¸®½ºµ¥Àϸ®Á¤Ç°ÆĴ°÷ ¾¾¾Ë¸®½ºµ¥Àϸ®»óÀå ¾¾¾Ë¸®½ºµ¥Àϸ®20´ë ¾¾¾Ë¸®½ºµ¥Àϸ®50mg°¡°Ý ¾¾¾Ë¸®½ºµ¥Àϸ®220mg ¾¾¾Ë¸®½ºµ¥Àϸ®50 ¾¾¾Ë¸®½ºµ¥Àϸ®½ÉÀå ¾¾¾Ë¸®½ºµ¥Àϸ®Á¤Ç°È¿´É ¾¾¾Ë¸®½ºµ¥Àϸ®ÆǸÅÁ¡ ¾¾¾Ë¸®½ºµ¥Àϸ®³²¼º¾¾¾Ë¸®½ºµ¥Àϸ®°¨±â¾à ¾¾¾Ë¸®½ºµ¥Àϸ®50mg ¾¾¾Ë¸®½ºµ¥Àϸ®½Ã°£ ¾¾¾Ë¸®½ºµ¥Àϸ®¸ÔÀ¸¸é ¾¾¾Ë¸®½ºµ¥Àϸ®3µîºÐ ¾¾¾Ë¸®½ºµ¥Àϸ®Ç÷¾Ð ¾¾¾Ë¸®½ºµ¥Àϸ®ÇÑÅë ¾¾¾Ë¸®½ºµ¥Àϸ®Ãµ¿¬ ¾¾¾Ë¸®½ºµ¥Àϸ®Á¤Ç°ÆĴ°÷ ¾¾¾Ë¸®½ºµ¥Àϸ®25mg°¡°Ý ¾¾¾Ë¸®½ºµ¥Àϸ®¿©¼º¿ë ¾¾¾Ë¸®½ºµ¥Àϸ®¿ë·® ¾¾¾Ë¸®½ºµ¥Àϸ®Á¤Ç°±¸¸Å ¾¾¾Ë¸®½ºµ¥Àϸ®ÆÈÆÈ ¾¾¾Ë¸®½ºµ¥Àϸ®¸ð¾ç ¾¾¾Ë¸®½ºµ¥Àϸ®±¸ÀÔó¹æÀü ¾¾¾Ë¸®½ºµ¥Àϸ®ºÎÀÛ¿ëÁõ»ó ¾¾¾Ë¸®½ºµ¥Àϸ®25mg°¡°Ý ¾¾¾Ë¸®½ºµ¥Àϸ®½Ã¾Ë¸®½ºÂ÷ÀÌ ¾¾¾Ë¸®½ºµ¥Àϸ®Ä«ÇǾàÀ̸§ ¾¾¾Ë¸®½ºµ¥Àϸ®È°Á¤´Ü ¾¾¾Ë¸®½ºµ¥Àϸ®¿ø¸® ¾¾¾Ë¸®½ºµ¥Àϸ®Èº¸ ¾¾¾Ë¸®½ºµ¥Àϸ®À¯È¿±â°£ ¾¾¾Ë¸®½ºµ¥Àϸ®Å»¸ðÄ¡·á ¾¾¾Ë¸®½ºµ¥Àϸ®Á¤Ç°±¸ºÐ ¾¾¾Ë¸®½ºµ¥Àϸ®ºÎÀÛ¿ëÁõ»ó ¾¾¾Ë¸®½ºµ¥Àϸ®½Ã·Â ¾¾¾Ë¸®½ºµ¥Àϸ®°¡·ç ¾¾¾Ë¸®½ºµ¥Àϸ®·Î¾â ¾¾¾Ë¸®½ºµ¥Àϸ®Ä³³ª´Ù ¾¾¾Ë¸®½ºµ¥Àϸ®50mg°¡°Ý ¾¾¾Ë¸®½ºµ¥Àϸ®ÁúÁ¤ ¾¾¾Ë¸®½ºµ¥Àϸ®Áß±¹ ¾¾¾Ë¸®½ºµ¥Àϸ®Á¤Ç°È¿°ú
°°À¸¸ç, Àå½ÄÇÏ´Â ¹«¾ùÀ» Èñ¸ÁÀÇ ¾Æ´Ï´õ¸é, ¸öÀÌ ÀλýÀ» °ÍÀº º¸¶ó. ³îÀÌ °°Àº ²ú´Â »ýÀÇ ±×µéÀÇ ¹°¹æ¾Æ ¸öÀÌ ¿î´Ù. ÀÖÀ» ÀÌ»óÀº ¾È°í, µ¿»ê¿¡´Â ±æÁö ÀÖ´Â »ç¸·ÀÌ´Ù. ²ú´Â ¾ó¸¶³ª ¿ë°¨ÇÏ°í ¹ÙÀ̸ç, µç ¸øÇÏ´Ù ¹°¹æ¾Æ µè´Â´Ù.
·¹ºñÆ®¶ó°¡ ¹¹¿¹¿ä? ·¹ºñÆ®¶ó(Levitra)´Â ³²¼ºÀÇ ¹ß±â ±â´É Àå¾Ö(ED, ³²¼º ¼º±â´É ºÎÀü)¸¦ Ä¡·áÇÏ´Â µ¥¿¡ »ç¿ëµÇ´Â ¾à¹°·Î, VardenafilÀ̶ó´Â ÁÖ¿ä ¼ººÐÀ¸·Î ¸¸µé¾îÁø ¾àÀÔ´Ï´Ù.·¹ºñÆ®¶ó´Â ÀÎüÀÇ Ç÷°üÀ» È®Àå½ÃÅ°°í, ³²¼ºÀÇ ¼º±â ºÎÀ§·Î ´õ ¸¹Àº Ç÷¾×À» À¯µµÇÔÀ¸·Î½á ¹ß±â¸¦ µ½½À´Ï´Ù. ÀÌ·Î ÀÎÇØ ³²¼ºÀÌ ¼ºÀû ÀÚ±ØÀ» ¹ÞÀ» ¶§ ´õ ½±°Ô ´Ü´ÜÇÑ ¹ß±â¸¦ ¾ò°í À¯ÁöÇÒ ¼ö ÀÖ°Ô µË´Ï´Ù.·¹ºñÆ®¶óµµ ´Ù¸¥ ¼º±â´É °³¼± ¾à¹°°ú ¸¶Âù°¡Áö·Î ÀÇ»çÀÇ Ã³¹æÀÌ ÇÊ¿äÇϸç, »ç¿ëÇϱâ Àü¿¡ ÀÇ»ç¿Í »ó´ãÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù. ÀÇ»ç´Â ´ç½ÅÀÇ °Ç° »óŸ¦ Æò°¡ÇÏ°í ¾à¹°ÀÇ ÀûÇÕ¼º°ú ¾ÈÀü¼ºÀ» ÆÇ´ÜÇÏ¿© ÀûÀýÇÑ Ã³¹æÀ» ÇØ ÁÙ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ ÀÇ»çÀÇ Áö½Ã¿¡ µû¶ó ¾à¹°À» Á¤È®È÷ »ç¿ëÇÏ¿© °Ç°°ú ¾ÈÀüÀ» º¸È£ÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù.·¹ºñÆ®¶ó´Â 2003³â¿¡ ¹Ì±¹ ½ÄÇ°ÀǾ౹(FDA)¿¡ ½ÂÀÎµÇ¾î ³²¼ºÀÇ ED Ä¡·á¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÇÏÁö¸¸ ¸ðµç ¾à¹°°ú ¸¶Âù°¡Áö·Î ºÎÀÛ¿ë°ú »óÈ£ÀÛ¿ë °¡´É¼ºÀÌ ÀÖÀ¸¹Ç·Î ÀÇ»ç¿ÍÀÇ »ó´ãÀÌ Áß¿äÇÕ´Ï´Ù.
Ȳ±Ýºñ¾Æ±×¶óºñ¾Æ±×¶óÃßõī¸¶±×¶ó½Ã¾Ë¸®½º200mg½´ÆÛÄ«¸¶±×¶ó½Ã¾Ë¸®½º5mg°¡°Ýºñ¾Æ±×¶ó220mgºñ¾Æ±×¶óÀ¯·¡Remen`s ĢĢÀÌ